pudexacianinium chloride
Sponsors
Astellas Pharma Inc, Astellas Pharma Global Development, Inc.
Conditions
Abdominolpelvic SurgeryBreast CancerHealthy VolunteersIntraoperative Ureter VisualizationLaparoscopic/Minimally Invasive Colorectal SurgeryMelanomaRenal ImpairmentSentinel Lymph Node Biopsy
Phase 1
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
CompletedNCT04878471
Start: 2021-06-02End: 2021-07-22Updated: 2024-10-16
A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well
CompletedNCT05495581
Start: 2022-08-25End: 2023-05-08Updated: 2024-12-04
Phase 2
A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery
CompletedNCT04238481
Start: 2020-10-06End: 2021-11-29Updated: 2024-10-24
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery
TerminatedNCT05457842
Start: 2022-08-10End: 2022-09-20Updated: 2024-11-20
Phase 3
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery
CompletedNCT05754333
Start: 2023-08-02End: 2025-01-16Updated: 2025-10-09
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease
CompletedNCT05999747
Start: 2024-03-19End: 2025-10-13Updated: 2025-11-05